SchneiderEBerminghamAPebodyR, et al. SARS, MERS, and other coronavirus infections. In: DLHeymann (ed.) Control of Communicable Diseases Manual. 20th edn.Washington, DC: American Public Health Association, 2015, pp. 539–549.
2.
MorawskaLMiltonDK.It is time to address airborne transmission of COVID-19. Clin Infect Dis. Epub ahead of print July2020. DOI: 10.1093/cid/ciaa939.
3.
NardellEANathavitharanaRR.Airborne spread of SARS-CoV-2 and a potential role for air disinfection. JAMA2020; 324(2): 141–142.
4.
ZhangWDuRHLiB, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect2020; 9(1): 386–389.
5.
TanZPhoonPHYZengLA, et al. Response and operating room preparation for the COVID-19 outbreak: a perspective from the National Heart Centre in Singapore. J Cardiothorac Vasc Anesth2020; 34(9): 2331–2337.
6.
DresMSonia BurrelSBoutolleauD, et al. SARS-CoV-2 does not spread through ECMO or dialysis membranes. Am J Respir Crit Care Med2020; 202(3): 458–460.
7.
LimM.The history of extracorporeal oxygenators. Anaesthesia2006; 61(10): 984–995.
8.
CascellaMRajnikMCuomoA, et al. Features, evaluation and treatment coronavirus (COVID-19). StatPearls [Internet]. Treasure Island, FL: StatPearls, 2020.
9.
ISO 7199:2016. Cardiovascular implants and artificial organs – Blood-gas exchangers (oxygenators).
10.
AlexanderJH.Long term blood oxygenation membranes. Theses and Dissertations - Biomedical Engineering. https://uknowledge.uky.edu/cbme_etds/28 (2015, accessed 10 June 2020).
11.
HinzJMolderJMHanekopGG, et al. Reduced sevoflurane loss during cardiopulmonary bypass when using a polymethylpentane versus a polypropylene oxygenator. Int J Artif Organs2013; 36: 233–239.
12.
WiesenackCWiesnerGKeylC, et al. In vivo uptake and elimination of isoflurane by different membrane oxygenators during cardiopulmonary bypass. Anesthesiology2002; 97: 133–138.
13.
Nigro NetoCDe SimoneFCassaraL, et al. Tricks, tips, and literature review on the adapted vaporize system to deliver volatile agents during cardiopulmonary bypass. Ann Card Anaesth2016; 19: 240–244.
14.
Nigro NetoCAndradeAJPLealE, et al. Development of a prototype anti-pollution filter for volatile anesthetics. Int J Artif Organs2020; 43(7): 476–481.